IShares Pharmaceuticals Financials
| IHE Etf | USD 68.80 0.34 0.50% |
Net Expense Ratio 0.004 | 3 y Sharp Ratio 0.15 |
IShares |
The data published in IShares Pharmaceuticals' official financial statements typically reflect IShares Pharmaceuticals' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving IShares Pharmaceuticals' quantitative information. For example, before you start analyzing numbers published by IShares accountants, it's essential to understand IShares Pharmaceuticals' liquidity, profitability, and earnings quality within the context of the iShares space in which it operates.
Please note, the presentation of IShares Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IShares Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of IShares Pharmaceuticals' management manipulating its earnings.
IShares Pharmaceuticals Etf Summary
IShares Pharmaceuticals competes with IShares Healthcare, SPDR SP, Invesco Dynamic, IShares Healthcare, and IShares Insurance. The fund generally will invest at least 80 percent of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. US Pharmaceuticals is traded on NYSEARCA Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NYSE ARCA Exchange |
| ISIN | US4642888360 |
| CUSIP | 464288836 |
| Region | North America |
| Investment Issuer | iShares |
| Etf Family | iShares |
| Fund Category | Sector |
| Portfolio Concentration | Health Care |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
IShares Pharmaceuticals Key Financial Ratios
IShares Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IShares Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare IShares Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IShares Pharmaceuticals competition to find correlations between indicators driving IShares Pharmaceuticals's intrinsic value. More Info.iShares Pharmaceuticals ETF is considered the top ETF in price to earning as compared to similar ETFs. It is rated fifth overall ETF in price to book as compared to similar ETFs fabricating about 0.07 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for iShares Pharmaceuticals ETF is roughly 14.33 . Comparative valuation analysis is a catch-all technique that is used if you cannot value IShares Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.iShares Pharmaceuticals Systematic Risk
IShares Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. IShares Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on iShares Pharmaceuticals correlated with the market. If Beta is less than 0 IShares Pharmaceuticals generally moves in the opposite direction as compared to the market. If IShares Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one iShares Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of IShares Pharmaceuticals is generally in the same direction as the market. If Beta > 1 IShares Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About IShares Pharmaceuticals Financials
What exactly are IShares Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include IShares Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential IShares Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although IShares Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in IShares Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IShares Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.IShares Pharmaceuticals Thematic Clasifications
iShares Pharmaceuticals ETF is part of several thematic ideas from Sector ETFs to Health Care ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasIShares Pharmaceuticals November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of IShares Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of iShares Pharmaceuticals ETF. We use our internally-developed statistical techniques to arrive at the intrinsic value of iShares Pharmaceuticals ETF based on widely used predictive technical indicators. In general, we focus on analyzing IShares Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build IShares Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.26) | |||
| Maximum Drawdown | 3.46 | |||
| Value At Risk | (1.42) | |||
| Potential Upside | 1.05 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Pharmaceuticals ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
The market value of iShares Pharmaceuticals is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is IShares Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Pharmaceuticals' market value can be influenced by many factors that don't directly affect IShares Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.